A database of FDA approved therapeutic peptides and proteins
ID1049 | ThPPIDTh1008 | NamePeginterferon alfa-2a | Peptide SequenceCDLPQTHSLGSRRTLMLLAQ Full view | Length165 | Functional ClassificationIb | DiseaseImmunological | BrandPegasys | CompanyHoffman-La Roche Inc | Physical AppearanceSterile, preservative-free, colorless to light yellow injectable solution | Route of AdministartionSubcutaneous Injection | CategoryImmunosuppressive Agents | TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2 |
ID1059 | ThPPIDTh1010 | NameInterferon alfa-n1 | Peptide SequenceCDLPQTHSLGSRRTLMLLAQ Full view | Length165 | Functional ClassificationIb | DiseaseInfectious /Immunological | BrandWellferon | CompanyGlaxoSmithKline | Physical AppearanceSolution | Route of AdministartionInjection | CategoryAntiviral Agents, Immunologic factors, Immunosuppressiv agents | TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2 |
ID1064 | ThPPIDTh1011 | NameDarbepoetin alfa | Peptide SequenceAPPRLICDSRVLERYLLEAK Full view | Length166 | Functional ClassificationIb | DiseaseHematological | BrandAranesp | CompanyAmgen Inc | Physical AppearanceSterile, colorless, preservative-free solution containing polysorbate | Route of AdministartionIntravenousor Subcutaneous administration | CategoryAnti-anemic Agents, Hematinics | TargetErythropoietin receptor |
ID1071 | ThPPIDTh1013 | NameEpoetin alfa | Peptide SequenceAPPRLICDSRVLERYLLEAK Full view | Length166 | Functional ClassificationIb | DiseaseHematological | BrandBinocrit | CompanySandoz | Physical AppearanceClear colourless solution | Route of AdministartionSubcutaneous and Intravenous infusion | CategoryAnti-anemic Agents, Hematinics | TargetErythropoietin receptor |
ID1072 | ThPPIDTh1013 | NameEpoetin alfa | Peptide SequenceAPPRLICDSRVLERYLLEAK Full view | Length166 | Functional ClassificationIb | DiseaseHematological | BrandEpocept | CompanyLupin pharma | Physical AppearanceN.A. | Route of AdministartionInjection | CategoryAnti-anemic Agents, Hematinics | TargetErythropoietin receptor |
ID1073 | ThPPIDTh1013 | NameEpoetin alfa | Peptide SequenceAPPRLICDSRVLERYLLEAK Full view | Length166 | Functional ClassificationIb | DiseaseHematological | BrandEpofit | CompanyIntas pharma | Physical AppearanceN.A. | Route of AdministartionN.A. | CategoryAnti-anemic Agents, Hematinics | TargetErythropoietin receptor |
ID1074 | ThPPIDTh1013 | NameEpoetin alfa | Peptide SequenceAPPRLICDSRVLERYLLEAK Full view | Length166 | Functional ClassificationIb | DiseaseHematological | BrandEpogen | CompanyAmgen Inc. | Physical AppearanceSterile, colorless liquid | Route of AdministartionSubcutaneous Injection | CategoryAnti-anemic Agents, Hematinics | TargetErythropoietin receptor |
ID1075 | ThPPIDTh1013 | NameEpoetin alfa | Peptide SequenceAPPRLICDSRVLERYLLEAK Full view | Length166 | Functional ClassificationIb | DiseaseHematological | BrandEpogin | CompanyChugai | Physical AppearanceN.A. | Route of AdministartionSubcutaneous or by Intravenous. | CategoryAnti-anemic Agents, Hematinics | TargetErythropoietin receptor |
ID1076 | ThPPIDTh1013 | NameEpoetin alfa | Peptide SequenceAPPRLICDSRVLERYLLEAK Full view | Length166 | Functional ClassificationIb | DiseaseHematological | BrandEprex | CompanyJanssen-Cilag. Ortho Biologics LLC | Physical AppearanceSolution | Route of AdministartionSubcutaneous and Intravenous infusion | CategoryAnti-anemic Agents, Hematinics | TargetErythropoietin receptor |
ID1077 | ThPPIDTh1013 | NameEpoetin alfa | Peptide SequenceAPPRLICDSRVLERYLLEAK Full view | Length166 | Functional ClassificationIb | DiseaseHematological | BrandNanokine | CompanyNanogen Pharmaceutical biotechnology, Vietnam) | Physical AppearanceSterile, white, lyophilized powder. The reconstituted preparation with 1 ml solvent (containing 0.9% benzyl alcohol) results in a clear, colorless solution. | Route of AdministartionInjection | CategoryAnti-anemic Agents, Hematinics | TargetErythropoietin receptor |
ID1078 | ThPPIDTh1013 | NameEpoetin alfa | Peptide SequenceAPPRLICDSRVLERYLLEAK Full view | Length166 | Functional ClassificationIb | DiseaseHematological | BrandProcrit | CompanyOrtho Biotech | Physical AppearanceSterile, colorless liquid in an isotonic sodium chloride/sodium citrate buffered solution or a sodium chloride/sodium phosphate buffered solution | Route of AdministartionIntravenous(IV) or Subcutaneous (SC) administration. | CategoryAnti-anemic Agents, Hematinics | TargetErythropoietin receptor |
ID1117 | ThPPIDTh1016 | NamePegfilgrastim | Peptide SequenceMTPLGPASSLPQSFLLKCLE Full view | Length175 | Functional ClassificationIb | DiseaseImmunological | BrandNeulasta | CompanyAmgen Inc. | Physical AppearanceSolution | Route of AdministartionSubcutaneous injection | CategoryImmunosuppressive Agents, Anti-neutropenic agents | TargetGranulocyte colony-stimulating factor receptor,Neutrophil elastase |
ID1120 | ThPPIDTh1017 | NameSargramostim | Peptide SequenceAPARSPSPSTQPWEHVNAIQ Full view | Length127 | Functional ClassificationIb | DiseaseImmunological | BrandLeucomax | CompanyNovartis | Physical AppearanceSolution | Route of AdministartionSubcutaneous and Intravenous infusion | CategoryImmunosuppressive Agents | TargetGranulocyte-macrophage colony-stimulating factor receptor subunit alpha,Interleukin-3 receptor subunit alpha,Cytokine receptor common subunit beta,Syndecan-2,Bone marrow proteoglycan |
ID1121 | ThPPIDTh1017 | NameSargramostim | Peptide SequenceAPARSPSPSTQPWEHVNAIQ Full view | Length127 | Functional ClassificationIb | DiseaseImmunological | BrandLeukine | CompanyBerlex Laboratories Inc | Physical AppearanceSterile, preserved (1.1% benzyl alcohol), injectable solution (500 mcg/mL) and also as sterile, white, preservative free lyophilized powder (250 mcg) that requires reconstitution with 1 mL sterile water for Injection | Route of AdministartionSubcutaneous Injection (SC) or Intravenous infusion (IV) | CategoryImmunosuppressive Agents | TargetGranulocyte-macrophage colony-stimulating factor receptor subunit alpha,Interleukin-3 receptor subunit alpha,Cytokine receptor common subunit beta,Syndecan-2,Bone marrow proteoglycan |
ID1135 | ThPPIDTh1019 | NamePeginterferon alfa-2b | Peptide SequenceCDLPQTHSLGSRRTLMLLAQ Full view | Length165 | Functional ClassificationIb | DiseaseImmunological | BrandPEG-Intron | CompanySchering Corp | Physical AppearancePowder | Route of AdministartionSubcutaneous injection | CategoryImmunosuppressive Agents | TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2 |
ID1136 | ThPPIDTh1019 | NamePeginterferon alfa-2b | Peptide SequenceCDLPQTHSLGSRRTLMLLAQ Full view | Length165 | Functional ClassificationIb | DiseaseImmunological | BrandUnitron PEG | CompanyN.A. | Physical AppearanceLyophilized powder | Route of AdministartionSubcutaneous injection | CategoryImmunosuppressive Agents | TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2 |
ID1180 | ThPPIDTh1023 | NameAnakinra | Peptide SequenceMRPSGRKSSKMQAFRIWDVN Full view | Length153 | Functional ClassificationIIa | DiseaseImmunological | BrandKineret | CompanyAmgen Inc | Physical AppearanceSterile, clear, colorless-to-white, preservative free solution | Route of AdministartionSubcutaneous (SC) administration | CategoryImmunosuppressive Agents, Anti-rheumatic agents | TargetInterleukin-1 receptor type 1 |
ID1226 | ThPPIDTh1030 | NameInterferon gamma-1b | Peptide SequenceCYCQDPYVKEAENLKKYFNA Full view | Length146 | Functional ClassificationIb | DiseaseImmunological | BrandActimmune | CompanyInterMune Inc | Physical AppearanceSterile, clear, colorless solution | Route of AdministartionSubcutaneous Injection | CategoryImmunosuppressive Agents | TargetInterferon gamma receptor 1,Interferon gamma receptor 2 |
ID1229 | ThPPIDTh1031 | NameInterferon Alfa-2a, Recombinant | Peptide SequenceCDLPQTHSLGSRRTLMLLAQ Full view | Length165 | Functional ClassificationIb | DiseaseImmunological | BrandRoferon A | CompanyHoffmann-La Roche Inc | Physical AppearanceSolution | Route of AdministartionSubcutaneous Injection | CategoryN.A. | TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2 |
ID1230 | ThPPIDTh1031 | NameInterferon Alfa-2a, Recombinant | Peptide SequenceCDLPQTHSLGSRRTLMLLAQ Full view | Length165 | Functional ClassificationIb | DiseaseImmunological | BrandVeldona | CompanyAmarillo Biosciences | Physical AppearanceN.A. | Route of AdministartionN.A. | CategoryN.A. | TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2 |
ID1242 | ThPPIDTh1033 | NameOprelvekin | Peptide SequenceGPPPGPPRVSPDPRAELDST Full view | Length177 | Functional ClassificationIb | DiseaseCancer/Haemetological | BrandNeumega | CompanyGenetics Institute Inc | Physical AppearanceSterile, lyophilized powder | Route of AdministartionSubcutaneous injection | CategoryCoagulants and Thrombotic Agents, Anti-neoplastic agents | TargetInterleukin-11 receptor subunit alpha |
ID1246 | ThPPIDTh1034 | NamePalifermin | Peptide SequenceSYDYMEGGDIRVRRLFCRTQ Full view | Length140 | Functional ClassificationIb | DiseaseCancer | BrandKepivance | CompanyAmgen Inc | Physical AppearanceSterile, lyophilized powder | Route of AdministartionIntravenous infusion | CategoryAnti-Mucositis Agents | TargetFibroblast growth factor receptor 2,Neuropilin-1,Fibroblast growth factor receptor 1,Fibroblast growth factor receptor 4,Fibroblast growth factor receptor 3,Basement membrane-specific heparan sulfate proteoglycan core protein |
ID1257 | ThPPIDTh1036 | NameAldesleukin | Peptide SequenceMAPTSSSTKKTQLQLEHLLL Full view | Length134 | Functional ClassificationIb | DiseaseCancer/Infectious | BrandProleukin | CompanyChiron Corp | Physical AppearanceSterile, white to off-white, lyophilized cake | Route of AdministartionIntravenous administration | CategoryAntineoplastic Agents, Anti-HIV agents | TargetInterleukin-2 receptor subunit beta,Interleukin-2 receptor subunit alpha,Cytokine receptor common subunit gamma |
ID1341 | ThPPIDTh1049 | NameInterferon beta-1a | Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view | Length166 | Functional ClassificationIb | DiseaseCancer/Infectious/Immunological | BrandAvonex | CompanyBiogen Inc | Physical AppearanceLyophilized powder vial, Sterile liquid as single used prefilled syringe and also available as single use prefilled autoinjector. | Route of AdministartionIntramuscular Injection | CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors | TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2 |
ID1342 | ThPPIDTh1049 | NameInterferon beta-1a | Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view | Length166 | Functional ClassificationIb | DiseaseCancer/Infectious/Immunological | BrandBetaferon | CompanyBayer | Physical AppearancePowder and solvent that are made upto make solution. | Route of AdministartionSubcutaneous Injection | CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors | TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2 |
ID1343 | ThPPIDTh1049 | NameInterferon beta-1a | Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view | Length166 | Functional ClassificationIb | DiseaseCancer/Infectious/Immunological | BrandBetaseron | CompanyMerck | Physical AppearanceSterile, white to off-white powder | Route of AdministartionSubcutaneous Injection | CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors | TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2 |
ID1344 | ThPPIDTh1049 | NameInterferon beta-1a | Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view | Length166 | Functional ClassificationIb | DiseaseCancer/Infectious/Immunological | BrandBlastoferon | CompanySidus | Physical AppearanceN.A. | Route of AdministartionN.A. | CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors | TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2 |
ID1345 | ThPPIDTh1049 | NameInterferon beta-1a | Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view | Length166 | Functional ClassificationIb | DiseaseCancer/Infectious/Immunological | BrandExtavia | CompanyNovartis | Physical AppearanceSterile, white to off-white powder | Route of AdministartionSubcutaneous Injection | CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors | TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2 |
ID1346 | ThPPIDTh1049 | NameInterferon beta-1a | Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view | Length166 | Functional ClassificationIb | DiseaseCancer/Infectious/Immunological | BrandRebif | CompanyMerck | Physical AppearanceSterile solution in a prefilled syringe or REBIF Rebidose autoinjector | Route of AdministartionSubcutaneous Injection | CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors | TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2 |
ID1376 | ThPPIDTh1057 | NameInterferon beta-1b | Peptide SequenceMSYNLLGFLQRSSNFQSQKL Full view | Length166 | Functional ClassificationIb | DiseaseImmunological | BrandBetaseron | CompanyBayer | Physical AppearanceSterile, white to off-white powder | Route of AdministartionSubcutaneous Injection | CategoryAdjuvants, Immunologic and Immunosuppressive Agents | TargetN.A. |
ID1377 | ThPPIDTh1057 | NameInterferon beta-1b | Peptide SequenceMSYNLLGFLQRSSNFQSQKL Full view | Length166 | Functional ClassificationIb | DiseaseImmunological | BrandBetaferon | CompanyBayer | Physical AppearancePowder and solvent that are made upto make solution. | Route of AdministartionSubcutaneous Injection | CategoryAdjuvants, Immunologic and Immunosuppressive Agents | TargetN.A. |
ID1378 | ThPPIDTh1057 | NameInterferon beta-1b | Peptide SequenceMSYNLLGFLQRSSNFQSQKL Full view | Length166 | Functional ClassificationIb | DiseaseImmunological | BrandExtavia | CompanyNovartis | Physical AppearanceSterile, white to off-white powder | Route of AdministartionSubcutaneous Injection | CategoryAdjuvants, Immunologic and Immunosuppressive Agents | TargetN.A. |
ID1379 | ThPPIDTh1058 | NameInterferon alfacon-1 | Peptide SequenceCDLPQTHSLGSRRTLMLLAQ Full view | Length165 | Functional ClassificationIb | DiseaseImmunological/Infectious | BrandINFERGEN | CompanyKadmon Pharmaceuticals, LLC. | Physical AppearanceSterile, clear, colorless, preservative-free liquid | Route of AdministartionSubcutaneous Injection | CategoryAntiviral Agents and Immunosuppressive Agents | TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2 |
ID1415 | ThPPIDTh1069 | NamePegvisomant | Peptide SequenceFPTIPLSRLFDNAMLRAHRL Full view | Length191 | Functional ClassificationIIa | DiseaseHormonal | BrandSOMAVERT | CompanyPfizer | Physical AppearanceSterile, white lyophilized powder | Route of AdministartionSubcutaneous Injection | CategoryHormone Replacement Agents | TargetB-lymphocyte antigen CD20,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c |
ID1451 | ThPPIDTh1082 | NameFilgrastim | Peptide SequenceMTPLGPASSLPQSFLLKCLE Full view | Length175 | Functional ClassificationIb | DiseaseImmunological | BrandN.A. | CompanyN.A. | Physical AppearanceN.A. | Route of AdministartionN.A. | CategoryImmunosuppressive Agents, Antineutropenic Agents and Hematopoietic Agents | TargetLutropin-choriogonadotropic hormone receptor,Follicle-stimulating hormone receptor |
ID1454 | ThPPIDTh1084 | NameBecaplermin | Peptide SequenceSLGSLTIAEPAMIAECKTRT Full view | Length109 | Functional ClassificationIb | DiseaseCardiac | BrandREGRANEX | CompanyOMJ Pharmaceuticals, Inc. San German, Puerto Rico | Physical AppearanceGel: 0.01 %; clear, colorless to straw-colored gel | Route of AdministartionExternal use only | CategoryAngiogenesis Inducing Agents | TargetT-cell surface glycoprotein CD1a,Major histocompatibility complex class I-related gene protein,Integrin alpha-L,T-lymphocyte activation antigen CD86,Low affinity immunoglobulin gamma Fc region receptor II-b,T-cell surface glycoprotein CD4,Integrin beta-1,Integrin alpha-V,Integrin beta-3 |
ID1456 | ThPPIDTh1086 | NameInterferon Alfa-2B, Recombinant | Peptide SequenceCDLPQTHSLGSRRTLMLLAQ Full view | Length165 | Functional ClassificationIb | DiseaseImmunological | BrandINTRON® A | CompanyMerck | Physical AppearancePowder or solution | Route of AdministartionIntramuscular, Subcutaneous, Intralesional, or Intravenous injection | CategoryImmunosuppressive Agents | TargetGranulocyte colony-stimulating factor receptor,Neutrophil elastase, Coagulation factor X,Coagulation factor XI,Coagulation factor VII,Coagulation factor VIII,Prothrombin,Prolow-density lipoprotein receptor-related protein 1,Vitamin K-dependent gamma-carboxylase, Platelet-derived growth factor receptor beta,Platelet-derived growth factor receptor alpha,Alpha-2-macroglobulin |
ID1465 | ThPPIDTh1089 | NamePalivizumab | Peptide SequenceVH region: QVTLRESG< Full view | Length120 | Functional ClassificationIIIa | DiseaseInfectious | BrandSynagis | CompanyMedImmune | Physical AppearanceSterile, preservative-free liquid solution | Route of AdministartionIntramuscular injection | CategoryAntiviral Agents | TargetN.A. |
ID1635 | ThPPIDTh1141 | NameEpoetin Zeta | Peptide SequenceAPPRLICDSRVLERYLLEAK Full view | Length166 | Functional ClassificationIb | DiseaseCancer | BrandRetacrit | CompanyNorbitec | Physical Appearancesolution for injection | Route of AdministartionN.A. | CategoryN.A. | TargetErythropoietin receptor |
ID1655 | ThPPIDTh1151 | NameSomatotropin Recombinant | Peptide SequenceFPTIPLSRLFDNAMLRAHRL Full view | Length192 | Functional ClassificationIb | DiseaseHormonal/Metabolic | BrandNutropinAQ | CompanyGenentech Inc. | Physical AppearanceSterile, white lyophilized powder intended for subcutaneous administration after reconstitution with Bacteriostatic Water | Route of AdministartionSubcutaneous administration | CategoryHormone Replacement Agents | TargetGrowth hormone receptor, Prolactin receptor |
ID1656 | ThPPIDTh1151 | NameSomatotropin Recombinant | Peptide SequenceFPTIPLSRLFDNAMLRAHRL Full view | Length192 | Functional ClassificationIb | DiseaseHormonal/Metabolic | BrandBioTropin | CompanyBio-Technology General (Israel) Ltd. | Physical AppearanceSterile, white, lyophilized powder | Route of AdministartionSubcutaneous administration | CategoryHormone Replacement Agents | TargetGrowth hormone receptor, Prolactin receptor |
ID1657 | ThPPIDTh1151 | NameSomatotropin Recombinant | Peptide SequenceFPTIPLSRLFDNAMLRAHRL Full view | Length192 | Functional ClassificationIb | DiseaseHormonal/Metabolic | BrandProtropin | CompanyGenentech Inc. | Physical AppearanceSterile, white, lyophilized powder | Route of AdministartionIntramuscular or subcutaneous administration | CategoryHormone Replacement Agents | TargetGrowth hormone receptor, Prolactin receptor |
ID1817 | ThPPIDTh1208 | NameMetreleptin | Peptide SequenceMVPIQKVQDDTKTLIKTIVT Full view | Length147 | Functional ClassificationIb | DiseaseAdjunct therapy | BrandMyalept | CompanyAmylin Pharmaceuticals, LLC | Physical AppearanceLyophilized Powder for Solution | Route of AdministartionSubcutaneous | Category | TargetLeptin receptor |
ID1849 | ThPPIDTh1237 | NameSomatropin recombinant | Peptide SequenceFPTIPLSRLFDNAMLRAHRL Full view | Length191 | Functional ClassificationIb | DiseaseHormonal Disorders | BrandBioTropin | CompanyBiotech General | Physical AppearancePowder and Solvent for Solution | Route of AdministartionSubcutaneous | CategoryHormones, Hormone Substitutes, and Hormone Antagonists | TargetGrowth hormone receptor, Prolactin receptor |
ID1850 | ThPPIDTh1237 | NameSomatropin recombinant | Peptide SequenceFPTIPLSRLFDNAMLRAHRL Full view | Length191 | Functional ClassificationIb | DiseaseHormonal Disorders | BrandNutropinAQ | CompanyGenentech Inc. | Physical AppearanceSterile liquid | Route of AdministartionSubcutaneous | CategoryHormones, Hormone Substitutes, and Hormone Antagonists | TargetGrowth hormone receptor, Prolactin receptor |